Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jennifer Taubert
Pharma
J&J logs strong innovative drug sales despite Stelara's decline
For the first time, J&J’s global innovative medicines sales have reached more than $15 billion in a single quarter.
Fraiser Kansteiner
Jul 16, 2025 11:19am
J&J upholds sales growth confidence as Stelara biosims file in
Jan 22, 2025 11:26am
J&J accounts for Medicare price talks in 2030 growth projections
Jul 17, 2024 11:02am
J&J keeps the heat on Tremfya's rivals with at-home injector nod
Mar 1, 2019 10:28am
Pharma CEOs in Washington: The latest from the Senate pricing hearing
Feb 26, 2019 12:34pm
